Patents by Inventor Thomas Ciossek

Thomas Ciossek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for diagnosis and treatment of MDK1 signal transduction disorders
    Publication number: 20030104407
    Abstract: The present invention relates to MDK1 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing.
    Type: Application
    Filed: February 12, 2002
    Publication date: June 5, 2003
    Applicant: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften, e.V.
    Inventors: Thomas Ciossek, Axel Ullrich, Birgit Millauer
  • MDK1 polypeptides
    Patent number: 6361984
    Abstract: The present invention relates to MDK1 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for diseases or conditions characterized by an abnormality in a signal transduction disorder. The signal transduction pathway involves an interaction between a MDK1 receptor tyrosine kinase and a receptor for the kinase. The MDK1 receptor tyrosine kinase may be truncated and lack a kinase domain and may be selected from the group consisting of MDK1.T1, MDK1.T2, MDK1.&Dgr;1 and MDK1.&Dgr;2.
    Type: Grant
    Filed: May 9, 1995
    Date of Patent: March 26, 2002
    Assignee: Max-Planck-Gesellschaft zur Forderung der Weissenschaften
    Inventors: Thomas Ciossek, Axel Ullrich, Birgit Millauer
  • MDKI, a novel receptor tyrosine kinase
    Patent number: 6300482
    Abstract: The present invention relates to MDK1 polypeptides, nucleic acids encoding such polypeptides, cells, tissues and animals containing such nucleic acids, antibodies to such polypeptides, assays utilizing such polypeptides, and methods relating to all of the foregoing. Methods for treatment, diagnosis, and screening are provided for diseases or conditions characterized by an abnormality in a signal transduction disorder. The signal transduction pathway involves an interaction between a MDK1 receptor tyrosine kinase and a receptor for the kinase. The MDK1 receptor tyrosine kinase may be truncated and lack a kinase domain and may be selected from the group consisting of MDK1.T1, MDK1.T2, MDK1.&Dgr;1 and MDK1.&Dgr;2.
    Type: Grant
    Filed: January 3, 1995
    Date of Patent: October 9, 2001
    Assignee: Max-Flanck-Gesellschaft Zuer For{overscore (d)}erung Der
    Inventors: Thomas Ciossek, Axel Ullrich, Birgit Millauer